4-(2-Fluoro-phenyl)-tetrahydro-pyran-4-carboxylic acid, 95.0%, 250mg

(2R,3R,4S,5R)-2-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 97.0%, 10g

3-Methyl-3-phenylpyrrolidine-2,5-dione, 98.0%, 5g

1-(2-METHOXY-1,1-DIMETHYL-ETHYL)PYRAZOLE-4-BORONIC ACID PINACOL ESTER, 95.0%, 500mg

(2R,3R,4R,5R,6S)-2-Methoxy-6-methyltetrahydro-2H-pyran-3,4,5-triol, 95+%, 250mg

2-Chloro-5-fluorophenol, 98.0%, 10g

(1S,2R)-2-Methylcyclohexanamine hydrochloride, 95.0%, 100mg

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 60 m, Ø-Innen 0,32 mm, Filmd. 1,00 µm, 1 Stück

(1,2,3,4-Tetrahydroisoquinolin-3-yl)methanol, 95.0%, 1g

Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxylate, 97%, 100mg

(Z)-TETRACOS-15-ENOIC ACID, 95.0%, 1g

9,3':6',9''-Tercarbazole>98.0%(HPLC)(N)1g

5-METHYL-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXYLIC ACID, 95.0%, 50mg